Cue Biopharma, Inc.

Contributing Author

Recent Articles by Cue Biopharma, Inc.

Jun-24	Cue Biopharma Receives FDA Feedback on Pre-IND Briefing Document Reinforcing Company's Intention to Advance IND Submission for CUE-401 to Address Unmet Need in the Treatment of Autoimmune Disease CUE GlobeNewswire
May-12	Cue Biopharma Reports First Quarter 2025 Financial Results and Recent Business Highlights CUE GlobeNewswire
May-08	Cue Biopharma to Host Virtual Investor Event on May 15, 2025 CUE GlobeNewswire
May-05	Cue Biopharma to Participate in Fireside Chat at the Citizens Life Sciences Conference CUE GlobeNewswire